ArticleOpen forum infectious diseases2019

Influence of Diagnostic Method on Outcomes in Phase 3 Clinical Trials of Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: A Post Hoc Analysis of MODIFY I/II.

Mark H Wilcox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.